GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dongkoo Bio&Pharma Co Ltd (XKRX:006620) » Definitions » Gross-Profit-to-Asset %

Dongkoo Bio&Pharma Co (XKRX:006620) Gross-Profit-to-Asset % : 57.85% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Dongkoo Bio&Pharma Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Dongkoo Bio&Pharma Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was ₩144,132 Mil. Dongkoo Bio&Pharma Co's average Total Assets over the quarter that ended in Mar. 2025 was ₩249,137 Mil. Therefore, Dongkoo Bio&Pharma Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 57.85%.


Dongkoo Bio&Pharma Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Dongkoo Bio&Pharma Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dongkoo Bio&Pharma Co Gross-Profit-to-Asset % Chart

Dongkoo Bio&Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.19 61.81 72.19 72.80 69.87

Dongkoo Bio&Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.44 66.90 71.58 57.67 57.85

Competitive Comparison of Dongkoo Bio&Pharma Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Dongkoo Bio&Pharma Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dongkoo Bio&Pharma Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dongkoo Bio&Pharma Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Dongkoo Bio&Pharma Co's Gross-Profit-to-Asset % falls into.


;
;

Dongkoo Bio&Pharma Co Gross-Profit-to-Asset % Calculation

Dongkoo Bio&Pharma Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=152029.648/( (191102.905+244060.5)/ 2 )
=152029.648/217581.7025
=69.87 %

Dongkoo Bio&Pharma Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=144131.664/( (244060.5+254213.597)/ 2 )
=144131.664/249137.0485
=57.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Dongkoo Bio&Pharma Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Dongkoo Bio&Pharma Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dongkoo Bio&Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
B-14F, M State Building, 114, Beobwonro, Songpagu, Seoul, KOR, 05836
Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.

Dongkoo Bio&Pharma Co Headlines

No Headlines